BIOPHYTIS (ALBPS.PA) Forecast, Price Target & Analyst Ratings
EPA:ALBPS • FR001400OLP5
0.05 EUR
+0 (+0.2%)
Last: Mar 3, 2026, 07:00 PM
View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for BIOPHYTIS (ALBPS.PA).
Forecast Snapshot
Consensus Price Target
€0.79
+ 1,470.80% Upside
Next Earnings Forecast
Release DateJul 9, 2026
ChartMill Buy Consensus
84.44%
Weighted Analyst Rating Score
Price Target Details & History
Consensus Price Target and Range
Mean target
€0.79
Upside
+ 1,470.80%
From current price of €0.05 to mean target of €0.79, Based on 9 analyst forecasts
Low
€0.78
Median
€0.79
High
€0.81
Price Target Revisions
1 Month
0.00%
3 Months
0.00%
Price Target Summary
9 analysts have analysed ALBPS.PA and the average price target is 0.79 EUR. This implies a price increase of 1470.8% is expected in the next year compared to the current price of 0.05.
Analyst Ratings & History
Current Analyst Ratings
Analyst Ratings History
Analyst Ratings Consensus
ChartMill Buy Consensus
84.44%
ALBPS.PA was analyzed by 9 analysts. The buy percentage consensus is at 84. So analysts seem to be very confident about ALBPS.PA.
In the previous month the buy percentage consensus was at a similar level.
ALBPS.PA was analyzed by 9 analysts. More opinions would make the average more meaningful.
Recent Upgrades & Downgrades
Next Earnings Forecast Details
Next Earnings Details
Release DateJul 9, 2026
Next Earnings Revisions
Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
N/A
EPS (3 Months)
N/A
Next Earnings Summary
Full Analyst Estimates
Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY % growth | N/A | N/A 33.33% | |||||||||||
| EBITDA YoY % growth | -4.978M | -7.775M -56.19% | -9.704M -24.81% | -13.634M -40.50% | -15.42M -13.10% | -13.662M 11.40% | -26.504M -94.00% | -22.788M 14.02% | -13.53M 40.63% | -8.016M 40.75% | N/A -6.01% | N/A -87.88% | |
| EBIT YoY % growth | -5.043M | -7.942M -57.49% | -9.908M -24.75% | -13.861M -39.90% | -15.682M -13.14% | -13.942M 11.10% | -26.815M -92.33% | -23.272M 13.21% | -14.333M 38.41% | -8.5M 40.70% | N/A -6.03% | N/A -77.14% | |
| Operating Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | |
| EPS YoY % growth | N/A | N/A | N/A | N/A 7.61% | N/A -34.12% | N/A 80.70% | N/A 179.60% | N/A -134.26% | N/A 75.00% | N/A 65.17% | N/A 48.09% | N/A -34.10% |
All data in EUR
Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in EUR
Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data
Long Term Forward Growth Forecast Summary
Long Term EPS Growth (CAGR)
EPS Next 3 Year
N/A
EPS Next 5 Year
N/A
Long Term Revenue Growth (CAGR)
Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A
Long Term EBIT Growth (CAGR)
EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
BIOPHYTIS / ALBPS.PA Forecast FAQ
Can you provide the average price target for BIOPHYTIS stock?
9 analysts have analysed ALBPS.PA and the average price target is 0.79 EUR. This implies a price increase of 1470.8% is expected in the next year compared to the current price of 0.05.
What is the next earnings date for ALBPS stock?
BIOPHYTIS (ALBPS.PA) will report earnings on 2026-07-09.
Can you provide the consensus rating for BIOPHYTIS stock?
The consensus rating for BIOPHYTIS (ALBPS.PA) is 84.4444 / 100 . This indicates that analysts generally have a positive outlook on the stock.